etomoxir has been researched along with Graft vs Host Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Byersdorfer, CA; Ferrara, JL; Glick, GD; Goodell, S; Opipari, AW; Sandquist, S; Swanson, J; Tkachev, V | 1 |
1 other study(ies) available for etomoxir and Graft vs Host Disease
Article | Year |
---|---|
Effector T cells require fatty acid metabolism during murine graft-versus-host disease.
Topics: Animals; Blotting, Western; Bone Marrow Transplantation; Carnitine O-Palmitoyltransferase; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids; Female; Flow Cytometry; Graft vs Host Disease; Lymphocyte Activation; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Reverse Transcriptase Polymerase Chain Reaction; T-Lymphocyte Subsets; Transcription Factors; Transplantation, Homologous | 2013 |